0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover655.85%IV-1452.80%PremiumDec 20, 2024Expiry Date4.68Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8246Delta0.5593Gamma0.07Leverage Ratio-0.0027Theta-0.0013Rho-0.06Eff Leverage0.0002Vega
Biomerica Stock Discussion
Mobix Labs Acquires Spacecraft Components in $18M-$24M Deal
Benzinga· Nov
📊⚡️📊
👀
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
Biomerica (NASDAQ: BMRA) has secured three key patent allowances in European markets for its inFoods® Technology, targeting GERD, Crohn's Disease, and Ulcerative Colitis. The patents cover major European markets including Germany, UK, France, Italy, Spain, and over 30 other EPO nations. These markets represent significant opportunities: GERD ...
just
Biomerica Secures Three Key International Patents for Infoods® Technology to Address Gerd, Crohn’s Disease, and Ulcerative Colitis
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
No comment yet